Terrence, C. DAHL,Munir, A. HUSSAIN,Robert, A. LIPPER,Robert, L. JERZEWSKI,Mark, M. MENNING,Reza OLIYAI,Taiyin YANG
申请号：
HK16105492.4
公开号：
HK1217635A
申请日:
2016.05.13
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenovofir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation. In another embodiment a composition comprising tenovofir DF and a surfactant is claimed.
